Mechanistic Insights into ADAR1-p110 Nuclear Import: A Dual-Interface Interaction with Transportin-1
Year: 2026
Type: preprint
Abstract: The human ADAR1 exists as two isoforms: the predominantly cytoplasmic-localized p150, recognized for its role in suppression of aberrant immune activation, and the predominantly nuclear-localized p110 (missing the N terminal Zα domain), whose biological functions remain less understood but are thought to rely heavily on its subcellular localization. Despite its structural similarity to the Zα domain unique to ADAR1-p150, the functional significance of the Zβ domain shared by both isoforms remains unclear. Here, we identify an additional mechanism contributing to the nuclear import of ADAR1-p110 through a dual-interface interaction with transportin-1 (TNPO1), involving both the Zβ and dsRBD3 domains of ADAR1. Using cryo-electron microscopy, we show that Zβ engages TNPO1 at its canonical cargo-binding groove, while dsRBD3 binds at a peripheral site overlapping the RanGTP binding interface. Structure-guided mutagenesis and biochemical analyses support the contribution of Zβ to TNPO1 recognition. Disruption of the interaction between ADAR1 Zβ domain and TNPO1 alters the nucleocytoplasmic distribution of ADAR1-p110, resulting in increased cytoplasmic accumulation despite the retention of the previously characterized dsRBD3-associated nuclear localization signal. Furthermore, cytoplasmic redistribution of ADAR1-p110 mutants is accompanied by global suppression of cytosolic innate immune signaling pathways and reduced expression of interferon-stimulated genes. Together, these findings identify ADAR1 Zβ as an additional TNPO1-recognition element synergizing with dsRBD3 that contributes to ADAR1-p110 nuclear localization and highlight the relationship between its subcellular distribution and immune regulatory activity.
Language: English
Topic: RNA regulation and disease
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7236833353
